Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Work In Process (2016)

Historic Work In Process for Integra Lifesciences Holdings (IART) over the last 7 years, with Q3 2016 value amounting to $48.4 million.

  • Integra Lifesciences Holdings' Work In Process changed N/A to $48.4 million in Q3 2016 from the same period last year, while for Sep 2016 it was $48.4 million, marking a year-over-year change of. This contributed to the annual value of $48.0 million for FY2015, which is 439.34% down from last year.
  • Latest data reveals that Integra Lifesciences Holdings reported Work In Process of $48.4 million as of Q3 2016.
  • Integra Lifesciences Holdings' Work In Process' 5-year high stood at $53.2 million during Q1 2015, with a 5-year trough of $36.8 million in Q1 2012.
  • In the last 5 years, Integra Lifesciences Holdings' Work In Process had a median value of $47.8 million in 2014 and averaged $45.6 million.
  • Its Work In Process has fluctuated over the past 5 years, first surged by 2092.43% in 2013, then plummeted by 439.34% in 2015.
  • Integra Lifesciences Holdings' Work In Process (Quarter) stood at $40.1 million in 2012, then rose by 18.31% to $47.4 million in 2013, then grew by 5.83% to $50.2 million in 2014, then dropped by 4.39% to $48.0 million in 2015, then rose by 0.95% to $48.4 million in 2016.
  • Its last three reported values are $48.4 million in Q3 2016, $48.0 million for Q4 2015, and $53.2 million during Q1 2015.